Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Hepatic hydrothorax in patients with decompensated liver cirrhosis is a challenging problem. Treatment with diuretics and intermittent thoracentesis can be effective in selected patients. However, there are few effective therapeutic options in patients who are intolerant of these therapies. This study investigated the clinical usefulness of chemical pleurodesis with or without video-assisted thoracoscopic surgery (VATS) for patients with refractory hepatic hydrothorax. Methods: Eleven consecutive patients with refractory hepatic hydrothorax who underwent chemical pleurodesis with or without VATS between July 2007 and February 2011 were enrolled in this study. The medical records and radiologic imagings of these patients were thoroughly reviewed. Results: The median number of chemical pleurodesis sessions performed was 3 (range: 2-10). Successful pleurodesis was achieved in 8 of the 11 patients (72.7%),5 (62.5%) of whom remained asymptomatic and hydrothorax free for a median follow-up of 16 weeks (range: 2-52 weeks). Complications were low-grade fever/leukocytosis (n=11, 100%), pneumonia (n=1, 9.1%), pneumothorax (n=4, 36.4%),azotemia/acute renal failure (n=6, 54.6%), and hepatic encephalopathy (n=4, 36.4%). Five patients were suspected as having procedure-related mortality (45.5%) due to the occurrence of acute renal failure with hepatic failure. The overall survival was significantly longer in the success group than in the non-success group. Conclusions: Although chemical pleurodesis may improve the clinical symptoms and the radiologic findings in as many as 72.7% of patients with refractory hepatic hydrothorax, a significantly high prevalence of procedure-related morbidity and mortality hinders the routine application of this procedure for such patients.
Abstract
Background/Aims: Hepatic hydrothorax in patients with decompensated liver cirrhosis is a challenging problem. Treatment with diuretics and intermittent thoracentesis can be effective in selected patients. However, there are few effective therapeutic options in patients who are intolerant of these therapies. This study investigated the clinical usefulness of chemical pleurodesis with or without video-assisted thoracoscopic surgery (VATS) for patients with refractory hepatic hydrothorax. Methods: Eleven consecutive patients with refractory hepatic hydrothorax who underwent chemical pleurodesis with or without VATS between July 2007 and February 2011 were enrolled in this study. The medical records and radiologic imagings of these patients were thoroughly reviewed. Results: The median number of chemical pleurodesis sessions performed was 3 (range: 2-10). Successful pleurodesis was achieved in 8 of the 11 patients (72.7%),5 (62.5%) of whom remained asymptomatic and hydrothorax free for a median follow-up of 16 weeks (range: 2-52 weeks). Complications were low-grade fever/leukocytosis (n=11, 100%), pneumonia (n=1, 9.1%), pneumothorax (n=4, 36.4%),azotemia/acute renal failure (n=6, 54.6%), and hepatic encephalopathy (n=4, 36.4%). Five patients were suspected as having procedure-related mortality (45.5%) due to the occurrence of acute renal failure with hepatic failure. The overall survival was significantly longer in the success group than in the non-success group. Conclusions: Although chemical pleurodesis may improve the clinical symptoms and the radiologic findings in as many as 72.7% of patients with refractory hepatic hydrothorax, a significantly high prevalence of procedure-related morbidity and mortality hinders the routine application of this procedure for such patients.
참고문헌 (16)
- Morrow CS, "Hepatic hydrothorax", Ann Intern Med, 49, pp.193~203 (1958)
- Strauss RM, "Hepatic hydrothorax", Semin Liver Dis, 17, pp.227~232 (1997)
- Alberts WM, "Hepatic hydrothorax. Cause and management", Arch Intern Med, 151, pp.2383~2388 (1991)
- Xiol X, "Hepatic hydrothorax", Curr Opin Pulm Med, 4, pp.239~242 (1998)
- Massard G, "Minimally invasive management for first and recurrent pneumothorax", Ann Thorac Surg, 66, pp.592~599 (1998)
- Ikard RW, "Persistent hepatic hydrothorax after peritoneojugular shunt", Arch Surg, 115, pp.1125~1127 (1980)
- Runyon BA, "Hepatic hydrothorax is a relative contraindication to chest tube insertion", Am J Gastroenterol, 81, pp.566~567 (1986)
- Ferrante D, "Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax", Am J Gastroenterol, 97, pp.3172~3175 (2002)
- Arroyo V, "Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club", Hepatology, 23, pp.164~176 (1996)
- Strauss RM, "Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax", Am J Gastroenterol, 89, pp.1520~1522 (1994)
- Andrade RJ, "Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites", J Clin Gastroenterol, 22, pp.305~307 (1996)
- Gordon FD, "The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt", Hepatology, 25, pp.1366~1369 (1997)
- Chalasani N, "Transjugular intrahepatic portosystemic shunt (Trends Pharmacal Sci) for refractory hepatic hydrothorax: good for the lungs, not so good for the liver", Hepatology, 26, pp.286~ (1997)
- Rubinstein D, "Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management", Gastroenterology, 88, pp.188~191 (1985)
- Mouroux J, "Management of pleural effusion of cirrhotic origin", Chest, 109, pp.1093~1096 (1996)
- Saito R, "Two cases of intractable hepatic hydrothorax successfully treated with nasal CPAP", Nihon Shokakibyo Gakkai Zasshi, 103, pp.1146~1151 (2006)